Entero Therapeutics, Inc. (ENTO)

NASDAQ: ENTO · IEX Real-Time Price · USD

1.230

+0.030 (2.50%)

At close: Jun 28, 2024, 3:58 PM

1.240

+0.010 (0.81%)

After-hours: Jun 28, 2024, 7:31 PM EDT

Entero Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2014
Net Income	-16.1	-14.97	-84.52	-41.73	-15.18	Upgrade
Depreciation & Amortization	0.03	0.03	0.54	0.56	1.02	Upgrade
Share-Based Compensation	1.13	0.97	1.37	0.55	1.18	Upgrade
Other Operating Activities	2.25	-8.71	24.34	20.34	-1.06	Upgrade
Operating Cash Flow	-12.38	-22.34	-32.29	-11.22	-14.03	Upgrade
Capital Expenditures	0	0	-0.07	0.09	-0.02	Upgrade
Other Investing Activities	-0.5	-	-10.25	-	-	Upgrade
Investing Cash Flow	-0.5	0	-10.32	0.09	-0.02	Upgrade
Share Issuance / Repurchase	15.83	23.05	37.57	0.99	9.48	Upgrade
Debt Issued / Paid	-0.6	-0.64	0.09	2.86	3.61	Upgrade
Other Financing Activities	0	-6.67	7.11	13.2	0.06	Upgrade
Financing Cash Flow	15.23	15.74	44.76	17.05	13.14	Upgrade
Exchange Rate Effect	0	-0.26	0.03	-0.03	-0.03	Upgrade
Net Cash Flow	2.35	-6.6	2.16	5.91	-0.91	Upgrade
Free Cash Flow	-12.38	-22.34	-32.36	-11.13	-14.06	Upgrade
Free Cash Flow Per Share	-36.80	-622.19	-15226.08	-16445.22	-26328.25	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).